271 research outputs found

    Demographics and 30-Day Readmissions for End-Stage Renal Disease Patients

    Get PDF
    End-stage renal disease (ESRD) is increasingly a problem in the United States, and factors such as race/ethnicity and gender may not only worsen the risk of the disease but also correspond to worse treatment access. This is significant because ESRD is a heavy economic burden not only on patients, but on caregivers and the health care system, especially as disparities remain between different demographic groups. The purpose of this quantitative nonexperimental, historical, correlational design was to determine the extent to which gender and race/ethnicity predict 30-day readmission rates after hospitalization for ESRD patients. The theoretical framework for the current study was the theory of the determinants of avoidable readmissions in ESRD. The three research questions were to what extent patient gender predicts 30-day hospital readmission rate for ESRD patients, to what extent does patient race/ethnicity predicts 30-day hospital readmission rates, and are there any significant interactions terms in a combined prediction model using gender and race/ethnicity. Data were gathered from Data.gov and the United States Renal Data System. Regression analysis was used to analyze the data. The study found that gender, race, and income can all be predictors of ESRD hospitalization. The results have important implications for improving interventions to reduce ESRD hospitalization, thereby leading to positive social change by reducing both the personal and societal costs associated with the diseas

    Bacterial outer membrane vesicles and vaccine applications

    Get PDF
    Vaccines based on outer membrane vesicles (OMV) were developed more than 20 years ago against Neisseria meningitidis serogroup B. These nano-sized structures exhibit remarkable potential for immunomodulation of immune responses and delivery of “self” meningococcal antigens or unrelated antigens incorporated into the vesicle structure. This paper reviews different applications in OMV Research and Development (R&D) and provides examples of OMV developed and evaluated at the Finlay Institute in Cuba. A Good Manufacturing Practice (GMP) process was developed at the Finlay Institute to produce OMV from N. meningitidis serogroup B (dOMVB) using detergent extraction. Subsequently, OMV from N. meningitidis, serogroup A (dOMVA), serogroup W (dOMVW) and serogroup X (dOMVX) were obtained using this process. More recently, the extraction process has also been applied effectively for obtaining OMV on a research scale from Vibrio cholerae (dOMVC), Bordetella pertussis (dOMVBP), Mycobacterium smegmatis (dOMVSM) and BCG (dOMVBCG). The immunogenicity of the OMV have been evaluated for specific antibody induction, and together with functional bactericidal and challenge assays in mice have shown their protective potential. dOMVB has been evaluated with non-self neisserial antigens, including with a herpes virus type 2 glycoprotein, ovalbumin and allergens. In conclusion, OMV are proving to be more versatile than first conceived and remain an important technology for development of vaccine candidates. - See more at: http://journal.frontiersin.org/Journal/10.3389/fimmu.2014.00121/abstract#sthash.MwqUyZQ1.dpu

    Smoothies marketed in Spain: are they complying with labeling legislation?

    Get PDF
    There is no legal definition of a smoothie, so the European legislation applicable to its labeling is that of fruit juice. The smoothie market has grown in recent years, as it can include a wide variety of ingredients: fruits, fruit purees, honey, milk and vegetable milks, vegetables, herbs, cereals, cereal flours, seaweed, and crushed ice. In this study, 57 smoothies were reviewed. All of them were purchased in supermarkets and classified into eight types according to the main ingredients. Fifteen legal statements/items were reviewed on the pack labels: eleven mandatory and three optional. Moreover, nutrition labels, nutritional claims, images, marks, and other symbols were also reviewed. Only 22.8% of the samples complied with EU and Spanish labeling legislation. More incorrectness was related to the name of the food and the fruits included as main ingredients; other errors related to the allergy/intolerance statements, and some nutritional claims concerning vitamin C were also detected to a lesser extent. General advice is provided for consumers to interpret smoothie labels correctly. Lawmakers should amend legislation to accept the term “smoothie” as a legal name

    Bacterial adhesion on biomedical surfaces covered by yttria stabilized zirconia

    Get PDF
    The aim of this study was to compare the bacterial adhesion of Staphylococcus spp. on Ti-6Al-4V with respect to Ti-6Al-V modified alloys with a set of Cubic yttria stabilized zirconia (YSZ) and Ag-YSZ nanocomposite films. Silver is well known to have a natural biocidal character and its presence in the surface predicted to enhance the antimicrobial properties of biomedical surfaces. Microbial adhesion tests were performed using collection strains and twelve clinical strains of Staphylococcus aureus and Staphylococcus epidermidis. The adherence study was performed using a previously published protocol by Kinnari et al. Both collection strains and clinical isolates have shown lower bacterial adhesion to materials modified with respect to the alloy Ti-6Al-4V and the modification with silver reduced the bacterial adhesion for most of all the strains studied. Moreover the percentage of dead bacteria have been evaluated, demonstrating increased proportion of dead bacteria for the modified surfaces. Nanocrystalline silver dissolves releasing both Ag+ and Ag-0 whereas other silver sources release only Ag+. We can conclude that YSZ with nanocrystalline silver coating may lead to diminished postoperative infections and to increased corrosion and scratch resistance of YSZ incorporating alloys Ti-6Al-4V.Peer reviewe

    Supervision of milk coagulation with scatter red LED light

    Get PDF
    For cheese production clotting time is prederteminated using a proteolytic enzyme titulation test (Chamorro and Losada 2002). Thus an expert operator decides the optimum cutting time (always delayed compared to clotting time) based on his own subjective evaluation of textural and visual properties of the curd (Castillo et al. 2000). Expert judgment usually gives acceptable results, yet variability in the optimal assessment of cutting time leads to affects further cheese processing operations (pressing and ripening). The aforementioned reasons suggest the importance of an objective and non-destructive method to determinate optimal cutting time, which would allow indeed the automatic supervision of the cheese clotting process. The goal of this work is a prospective study for the supervision of milk coagulation with scatter red LED light

    1-(Benzo[d]thiazol-2-yl)-3-phenylureas as dual inhibitors of casein kinase 1 and ABAD enzymes for treatment of neurodegenerative disorders

    Get PDF
    This work was supported by the Ministry of Health of the Czech Republic [no. NV15-28967 A], Specific Research Project of Faculty of Science, University of Hradec Kralove [no. 2103-2017], National Institute of Mental Health [NIMH CZ; no. ED2.1.00/03.0078] from the European Regional Development Fund, COST CA15135, The Alzheimer’s Society (specifically The Barcopel Foundation), The Rosetrees trust and The Biotechnology and Biological Sciences Research Council (BBSRC) [no. BB/J01446X/1]. Funding from Ministry of Economy and competitiveness, Spain [no. SAF2012-37979-C03-01] is also acknowledged.Several neurodegenerative disorders including Alzheimer’s disease (AD) have been connected with deregulation of casein kinase 1 (CK1) activity. Inhibition of CK1 therefore presents a potential therapeutic strategy against such pathologies. Recently, novel class of CK1-specific inhibitors with N-(benzo[d]thiazol-2-yl)-2-phenylacetamide structural scaffold has been discovered. 1-(benzo[d]thiazol-2-yl)-3-phenylureas, on the other hand, are known inhibitors amyloid-beta binding alcohol dehydrogenase (ABAD), an enzyme also involved in pathophysiology of AD. Based on their tight structural similarity, we decided to evaluate series of previously published benzothiazolylphenylureas, originally designed as ABAD inhibitors, for their inhibitory activity towards CK1. Several compounds were found to be submicromolar CK1 inhibitors. Moreover, two compounds were found to inhibit both, ABAD and CK1. Such dual-activity could be of advantage for AD treatment, as it would simultaneously target two distinct pathological processes involved in disease’s progression. Based on PAMPA testing both compounds were suggested to permeate the blood-brain barrier, which makes them, together with their unique dual activity, interesting lead compounds for further development.Publisher PDFPeer reviewe

    Three-dimensional distribution of cortical synapses: a replicated point pattern-based analysis

    Full text link
    The biggest problem when analyzing the brain is that its synaptic connections are extremely complex. Generally, the billions of neurons making up the brain exchange information through two types of highly specialized structures: chemical synapses (the vast majority) and so-called gap junctions (a substrate of one class of electrical synapse). Here we are interested in exploring the three-dimensional spatial distribution of chemical synapses in the cerebral cortex. Recent research has showed that the three-dimensional spatial distribution of synapses in layer III of the neocortex can be modeled by a random sequential adsorption (RSA) point process, i.e., synapses are distributed in space almost randomly, with the only constraint that they cannot overlap. In this study we hypothesize that RSA processes can also explain the distribution of synapses in all cortical layers. We also investigate whether there are differences in both the synaptic density and spatial distribution of synapses between layers. Using combined focused ion beam milling and scanning electron microscopy (FIB/SEM), we obtained three-dimensional samples from the six layers of the rat somatosensory cortex and identified and reconstructed the synaptic junctions. A total volume of tissue of approximately 4500μm3 and around 4000 synapses from three different animals were analyzed. Different samples, layers and/or animals were aggregated and compared using RSA replicated spatial point processes. The results showed no significant differences in the synaptic distribution across the different rats used in the study. We found that RSA processes described the spatial distribution of synapses in all samples of each layer. We also found that the synaptic distribution in layers II to VI conforms to a common underlying RSA process with different densities per layer. Interestingly, the results showed that synapses in layer I had a slightly different spatial distribution from the other layers

    Experimental Phantom-Based Security Analysis for Next-Generation Leadless Cardiac Pacemakers

    Full text link
    [EN] With technological advancement, implanted medical devices can treat a wide range of chronic diseases such as cardiac arrhythmia, deafness, diabetes, etc. Cardiac pacemakers are used to maintain normal heart rhythms. The next generation of these pacemakers is expected to be completely wireless, providing new security threats. Thus, it is critical to secure pacemaker transmissions between legitimate nodes from a third party or an eavesdropper. This work estimates the eavesdropping risk and explores the potential of securing transmissions between leadless capsules inside the heart and the subcutaneous implant under the skin against external eavesdroppers by using physical-layer security methods. In this work, we perform phantom experiments to replicate the dielectric properties of the human heart, blood, and fat for channel modeling between in-body-to-in-body devices and from in-body-to-off-body scenario. These scenarios reflect the channel between legitimate nodes and that between a legitimate node and an eavesdropper. In our case, a legitimate node is a leadless cardiac pacemaker implanted in the right ventricle of a human heart transmitting to a legitimate receiver, which is a subcutaneous implant beneath the collar bone under the skin. In addition, a third party outside the body is trying to eavesdrop the communication. The measurements are performed for ultrawide band (UWB) and industrial, scientific, and medical (ISM) frequency bands. By using these channel models, we analyzed the risk of using the concept of outage probability and determine the eavesdropping range in the case of using UWB and ISM frequency bands. Furthermore, the probability of positive secrecy capacity is also determined, along with outage probability of a secrecy rate, which are the fundamental parameters in depicting the physical-layer security methods. Here, we show that path loss follows a log-normal distribution. In addition, for the ISM frequency band, the probability of successful eavesdropping for a data rate of 600 kbps (Electromyogram (EMG)) is about 97.68% at an eavesdropper distance of 1.3 m and approaches 28.13% at an eavesdropper distance of 4.2 m, whereas for UWB frequency band the eavesdropping risk approaches 0.2847% at an eavesdropper distance of 0.22 m. Furthermore, the probability of positive secrecy capacity is about 44.88% at eavesdropper distance of 0.12 m and approaches approximately 97% at an eavesdropper distance of 0.4 m for ISM frequency band, whereas for UWB, the same statistics are 96.84% at 0.12 m and 100% at 0.4 m. Moreover, the outage probability of secrecy capacity is also determined by using a fixed secrecy rate.This work was supported by the Marie Curie Research Grants Scheme, with project grant no 675353, EU Horizon 2020-WIBEC ITN 00 (Wireless In-Body Environment). Details can be found at a source https://cordis.europa.eu/project/rcn/198286_en.html.Awan, MF.; Perez-Simbor, S.; Garcia-Pardo, C.; Kansanen, K.; Cardona Marcet, N. (2018). Experimental Phantom-Based Security Analysis for Next-Generation Leadless Cardiac Pacemakers. Sensors. 18(12):1-24. https://doi.org/10.3390/s18124327S124181
    corecore